Hartmut Wekerle

Active 1973–2025

123
Papers
28,787
Citations
99
h-index
121
i10-index

Citations

Citations per year for Hartmut Wekerle1973: 1 citations1976: 2 citations1977: 3 citations1978: 2 citations1979: 1 citations1980: 3 citations1981: 16 citations1982: 13 citations1983: 15 citations1984: 17 citations1985: 22 citations1986: 39 citations1987: 70 citations1988: 83 citations1989: 59 citations1990: 80 citations1991: 75 citations1992: 85 citations1993: 77 citations1994: 98 citations1995: 185 citations1996: 119 citations1997: 131 citations1998: 217 citations1999: 221 citations2000: 204 citations2001: 274 citations2002: 240 citations2003: 233 citations2004: 240 citations2005: 247 citations2006: 273 citations2007: 175 citations2008: 204 citations2009: 211 citations2010: 233 citations2011: 214 citations2012: 224 citations2013: 246 citations2014: 290 citations2015: 285 citations2016: 241 citations2017: 256 citations2018: 291 citations2019: 658 citations2020: 669 citations2021: 621 citations2022: 512 citations2023: 408 citations2024: 501 citations2025: 243 citations2026: 14 citations1974–1975: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,782 citing papers, 28.3% of this breakdownGermany: 1,240 citing papers, 12.6% of this breakdownUnited Kingdom: 591 citing papers, 6% of this breakdownChina: 522 citing papers, 5.3% of this breakdownItaly: 466 citing papers, 4.8% of this breakdownCanada: 402 citing papers, 4.1% of this breakdownSwitzerland: 333 citing papers, 3.4% of this breakdownFrance: 321 citing papers, 3.3% of this breakdownAustria: 273 citing papers, 2.8% of this breakdownAustralia: 272 citing papers, 2.8% of this breakdownJapan: 256 citing papers, 2.6% of this breakdownNetherlands: 227 citing papers, 2.3% of this breakdown
0%28.3%Other 21.7%

Fields

  • Medicine41%
  • Neuroscience21.3%
  • Biochemistry, Genetics and Molecular Biology20.4%
  • Immunology and Microbiology15.5%
  • Agricultural and Biological Sciences0.5%
  • Nursing0.4%
  • Other0.9%

Topics

  • Multiple Sclerosis Research Studies7.6%
  • Neuroinflammation and Neurodegeneration Mechanisms7.5%
  • T-cell and B-cell Immunology5.4%
  • Immunotherapy and Immune Responses4.4%
  • Gut microbiota and health3.8%
  • Immune Response and Inflammation3%
  • Other68.3%

Coauthors

All papers

Open in search
  1. Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David Otaegui, Tamara Castillo‐Triviño, Stephen L. Hauser, Jeffrey M. Gelfand, Howard L. Weiner, Reinhard Hohlfeld, Hartmut Wekerle, Jennifer Graves, Amit Bar‐Or, Bruce Cree, Jorge Correale, Rob Knight, Sergio E. Baranzini - Cell 2022 cited by 319

  2. Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice

    Authors: , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2017 cited by 936

  3. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination

    Authors: , , , , , , , - Nature 2011 cited by 1,252

  4. γ-secretase directly sheds the survival receptor BCMA from plasma cells

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2015 cited by 364

  5. Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions

    Authors: , , , , , , , , , , - Nature 2009 cited by 682

  6. Broader Epstein–Barr virus–specific T cell receptor repertoire in patients with multiple sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2022 cited by 85

  7. MHC class II–dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies

    Authors: , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2013 cited by 415

  8. MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47

    Authors: , , , , , , , , , - Brain 2009 cited by 592

  9. T cells become licensed in the lung to enter the central nervous system

    Authors: , , , , , , , , , , , , , , , , , , - Nature 2012 cited by 438

  10. Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins

    Authors: , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 190

  11. Treg cells mediate recovery from EAE by controlling effector T cell proliferation and motility in the CNS

    Authors: , , , , - Acta Neuropathologica Communications 2014 cited by 129

  12. Activated Human T Cells, B Cells, and Monocytes Produce Brain-derived Neurotrophic Factor In Vitro and in Inflammatory Brain Lesions: A Neuroprotective Role of Inflammation?

    Authors: , , , , , , , , , , , , , - The Journal of Experimental Medicine 1999 cited by 1,024

  13. The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets

    Authors: , , , - The Lancet Neurology 2015 cited by 198

  14. Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells

    Authors: , , , , , , , , , - The Journal of Experimental Medicine 2009 cited by 291

  15. Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis

    Authors: , , , , , , , , - Nature Medicine 2008 cited by 290

  16. Neurotrophins inhibit major histocompatibility class II inducibility of microglia: Involvement of the p75 neurotrophin receptor

    Authors: , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1998 cited by 283

  17. Extracellular Matrix in Multiple Sclerosis Lesions: Fibrillar Collagens, Biglycan and Decorin are Upregulated and Associated with Infiltrating Immune Cells

    Authors: , , , , , , , , , , - Brain Pathology 2010 cited by 160

  18. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma

    Authors: , , , , , , , , , , , , - The Journal of Experimental Medicine 2005 cited by 483

  19. B Lymphocytes Producing Demyelinating Autoantibodies: Development and Function in Gene-targeted Transgenic Mice

    Authors: , , , , , , - The Journal of Experimental Medicine 1998 cited by 257

  20. From classic to spontaneous and humanized models of multiple sclerosis: Impact on understanding pathogenesis and drug development

    Authors: , , , , , , , - Journal of Autoimmunity 2014 cited by 159

  21. The rapid isolation of clonable antigen‐specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis

    Authors: , , - European Journal of Immunology 1981 cited by 918

  22. Functional and Pathogenic Differences of Th1 and Th17 Cells in Experimental Autoimmune Encephalomyelitis

    Authors: , , , , - PLoS ONE 2010 cited by 222

  23. Brain Autoimmunity and Intestinal Microbiota: 100 Trillion Game Changers

    Authors: - Trends in Immunology 2017 cited by 102

  24. Multiple sclerosis: Brain-infiltrating CD8 + T cells persist as clonal expansions in the cerebrospinal fluid and blood

    Authors: , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2004 cited by 346